Drug Profile
Research programme: malaria vaccine - Novavax/NIAID
Alternative Names: Baculovirus MSP1-42 vaccine - NIH/Novavax; Malaria MSP-1 vaccine - NIAID/SAIC/Novavax; Malaria MSP-1 vaccine - NIH/SAIC/NovavaxLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator National Institute of Allergy and Infectious Diseases; Novavax
- Class Antimalarials; Parasitic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Malaria
Most Recent Events
- 15 Jun 2006 No development reported - Preclinical for Malaria in USA (unspecified route)
- 29 Mar 2001 Preclinical trials in Malaria in USA (unspecified route)